Theranexus (EPA:ALTHX) | WebDisclosure

Basculer en Français

10355	Companies
215494	Keywords
145316	Articles
114163	Press releases

Home
Companies
Theranexus

PRESS RELEASE

published on 03/25/2026 at 18:45, 1 month 12 days ago

THX Pharma annonce la publication de sa lettre aux actionnaires
THX Pharma (Theranexus) annonce la publication de sa lettre aux actionnaires sur les traitements neurologiques rares. Découvrez les détails et inscrivez-vous pour recevoir les communications

Communications Lettre Aux Actionnaires Theranexus THX Pharma Traitements Neurologiques Rares
PRESS RELEASE

published on 03/25/2026 at 18:45, 1 month 12 days ago

THX Pharma Announces the Publication of its Letter to Shareholders
THX Pharma (Theranexus) announces the publication of a letter to shareholders regarding its innovative treatments for rare neurological diseases. Company details and contact information included

Shareholders Biopharmaceutical Theranexus Neurological Diseases THX Pharma
BRIEF

published on 02/25/2026 at 18:05, 2 months 9 days ago

THX Pharma increases the resources of its liquidity contract

Liquidity Contract Euronext Growth Biopharmaceutical Financial Resources THX Pharma
BRIEF

published on 02/25/2026 at 18:05, 2 months 9 days ago

THX Pharma augmente les moyens de son contrat de liquidité

Contrat De Liquidité Euronext Growth Biopharmaceutique Moyens Financiers THX Pharma
PRESS RELEASE

published on 02/25/2026 at 18:00, 2 months 9 days ago

THX Pharma annonce l'augmentation des moyens affectés au contrat de liquidité
THX Pharma augmente les moyens du contrat de liquidité confié à Portzamparc - BNP Paribas. Details des apports en titre et en espèces. Presentation de la société et de ses projets dans les maladies neurologiques rares. Contacts et déclarations prospectives

Contrat De Liquidité Déclarations Prospectives Industrie Pharmaceutique Maladies Neurologiques Rares THX Pharma
BRIEF

published on 02/19/2026 at 18:05, 2 months 15 days ago

THX Pharma renforce sa position financière au 31 décembre 2025

Partenariat Trésorerie Batten-1 TX01 Biocodex
BRIEF

published on 02/19/2026 at 18:05, 2 months 15 days ago

THX Pharma Announces Strong Cash Position at Year-End

Cash Position THX Pharma Biocodex Agreement Batten-1 Program TX01 Development
BRIEF

published on 02/19/2026 at 18:05, 2 months 15 days ago

THX Pharma annonce une solide trésorerie en fin d'année

THX Pharma Position De Trésorerie Accord Biocodex Programme Batten-1 Développement TX01
BRIEF

published on 02/19/2026 at 18:05, 2 months 15 days ago

THX Pharma strengthens its financial position as of December 31, 2025

Treasury Partnership Batten-1 TX01 Biocodex
PRESS RELEASE

published on 02/19/2026 at 18:00, 2 months 15 days ago

THX Pharma Reports Its Cash Position as of December 31, 2025
THX Pharma (Theranexus) announces cash position of €7.8 million as of Dec 31, 2025. Pro forma cash position reaches €21.7 million with incoming payment from Biocodex agreement. Company focused on rare neurological diseases treatments development

Cash Position Rare Neurological Diseases Therapeutic Solutions THX Pharma Biocodex Agreement

Accesswire

Published on 05/06/2026 at 23:30, 1 hour 5 minutes ago

Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 1 hour 30 minutes ago

Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 1 hour 35 minutes ago

Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance
Published on 05/06/2026 at 22:10, 2 hours 25 minutes ago

Banyan Gold Announces Closing of $46.5 Million Private Placement
Published on 05/06/2026 at 22:05, 2 hours 30 minutes ago

Pivotree Announces Resignation of Board Director Patrick Meneley

View all ACCESSWIRE

EQS Group

Published on 05/06/2026 at 20:32, 4 hours 3 minutes ago

EQS-Adhoc: Kontron AG: ADHOC Kontron AG / Potential Public Takeover Bid by Ennoconn Corporation
Published on 05/06/2026 at 20:22, 4 hours 13 minutes ago

EQS-Adhoc: ams-OSRAM AG: ams OSRAM delivers strong Q1 results, enters AI market through a development agreement with a leading AI photonics customer and sees path to positive Free Cash Flow in 2027
Published on 05/06/2026 at 19:18, 5 hours 17 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/06/2026 at 18:47, 5 hours 47 minutes ago

Amadeus Fire Group starts the current year on a positive note and confirms the forecast for the financial year 2026
Published on 05/06/2026 at 18:30, 6 hours 5 minutes ago

Avolta shareholders approve all proposals of the Board at the Ordinary General Meeting 2026

Les Echos

Published on 05/06/2026 at 18:00, 6 hours 35 minutes ago

Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 6 hours 35 minutes ago

Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 6 hours 35 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
Published on 05/06/2026 at 18:00, 6 hours 35 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2026
Published on 05/06/2026 at 17:45, 6 hours 50 minutes ago

Information concerning the total number of voting rights and shares 2026 04 30

View all LES ECHOS COMFI WIRE